Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
3.080
+0.070 (2.33%)
At close: Feb 21, 2025, 4:00 PM
3.090
+0.010 (0.32%)
After-hours: Feb 21, 2025, 7:32 PM EST
Pliant Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$14.86
Upside
+382.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +224.68% | Feb 14, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $45 → $4 | Buy → Hold | Downgrades | $45 → $4 | +29.87% | Feb 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $4 | Strong Buy → Hold | Downgrades | $4 | +29.87% | Feb 10, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $41 → $4 | Buy → Hold | Downgrades | $41 → $4 | +29.87% | Feb 10, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $44 → $4 | Strong Buy → Hold | Downgrades | $44 → $4 | +29.87% | Feb 10, 2025 |
| Needham | Needham | Strong Buy Maintains $38 → $10 | Strong Buy | Maintains | $38 → $10 | +224.68% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +1,133.77% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +1,133.77% | Sep 13, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +971.43% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +1,133.77% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $48 → $45 | Buy | Maintains | $48 → $45 | +1,361.04% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +1,133.77% | Aug 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.